Mier W - Search Results

1

Pharmacokinetic properties of peptidic radiopharmaceuticals: reduced uptake of (EH)3-conjugates in important organs.

Eder M, Löhr T, Bauder-Wüst U, Reber M, Mier W, Schäfer M, Haberkorn U, Eisenhut M. Eder M, et al. Among authors: mier w. J Nucl Med. 2013 Aug;54(8):1327-30. doi: 10.2967/jnumed.112.114512. Epub 2013 Jun 26. J Nucl Med. 2013. PMID: 23804326 Free article.

2

Radioiodinated N-(2-diethylaminoethyl)benzamide derivatives with high melanoma uptake: structure-affinity relationships, metabolic fate, and intracellular localization.

Eisenhut M, Hull WE, Mohammed A, Mier W, Lay D, Just W, Gorgas K, Lehmann WD, Haberkorn U. Eisenhut M, et al. Among authors: mier w. J Med Chem. 2000 Oct 19;43(21):3913-22. doi: 10.1021/jm991079p. J Med Chem. 2000. PMID: 11052796

3

Preparation and evaluation of tumor-targeting peptide-oligonucleotide conjugates.

Mier W, Eritja R, Mohammed A, Haberkorn U, Eisenhut M. Mier W, et al. Bioconjug Chem. 2000 Nov-Dec;11(6):855-60. doi: 10.1021/bc000041k. Bioconjug Chem. 2000. PMID: 11087334

4

Investigation of a potential scintigraphic marker of apoptosis: radioiodinated Z-Val-Ala-DL-Asp(O-methyl)-fluoromethyl ketone.

Haberkorn U, Kinscherf R, Krammer PH, Mier W, Eisenhut M. Haberkorn U, et al. Among authors: mier w. Nucl Med Biol. 2001 Oct;28(7):793-8. doi: 10.1016/s0969-8051(01)00247-5. Nucl Med Biol. 2001. PMID: 11578900

5

A new precursor for the radiosynthesis of [18F]FLT.

Martin SJ, Eisenbarth JA, Wagner-Utermann U, Mier W, Henze M, Pritzkow H, Haberkorn U, Eisenhut M. Martin SJ, et al. Among authors: mier w. Nucl Med Biol. 2002 Feb;29(2):263-73. doi: 10.1016/s0969-8051(01)00289-x. Nucl Med Biol. 2002. PMID: 11823132

6

[18F]FLT; portrait of a proliferation marker.

Mier W, Haberkorn U, Eisenhut M. Mier W, et al. Eur J Nucl Med Mol Imaging. 2002 Feb;29(2):165-9. doi: 10.1007/s00259-001-0675-3. Eur J Nucl Med Mol Imaging. 2002. PMID: 11926377 Review. No abstract available.

7

Pretreatment evaluation of carcinomas of the hypopharynx and larynx with 18F-fluorodeoxyglucose, 123I-alpha-methyl-L-tyrosine and 99mTc-hexakis-2-methoxyisobutylisonitrile.

Henze M, Mohammed A, Mier W, Rudat V, Dietz A, Nollert J, Eisenhut M, Haberkorn U. Henze M, et al. Among authors: mier w. Eur J Nucl Med Mol Imaging. 2002 Mar;29(3):324-30. doi: 10.1007/s00259-001-0703-3. Eur J Nucl Med Mol Imaging. 2002. PMID: 12002706 Clinical Trial.

8

Detection of tumour progression in the follow-up of irradiated low-grade astrocytomas: comparison of 3-[123I]iodo-alpha-methyl- L-tyrosine and 99mTc-MIBI SPET.

Henze M, Mohammed A, Schlemmer H, Herfarth KK, Mier W, Eisenhut M, Debus J, Haberkorn U. Henze M, et al. Among authors: mier w. Eur J Nucl Med Mol Imaging. 2002 Nov;29(11):1455-61. doi: 10.1007/s00259-002-0896-0. Epub 2002 Aug 20. Eur J Nucl Med Mol Imaging. 2002. PMID: 12397464 Clinical Trial.

9

Melanoma uptake of (99m)Tc complexes containing the N-(2-diethylaminoethyl)benzamide structural element.

Eisenhut M, Mohammed A, Mier W, Schönsiegel F, Friebe M, Mahmood A, Jones AG, Haberkorn U. Eisenhut M, et al. Among authors: mier w. J Med Chem. 2002 Dec 19;45(26):5802-5. doi: 10.1021/jm021026z. J Med Chem. 2002. PMID: 12477363

10

Peptide-PNA conjugates: targeted transport of antisense therapeutics into tumors.

Mier W, Eritja R, Mohammed A, Haberkorn U, Eisenhut M. Mier W, et al. Angew Chem Int Ed Engl. 2003 Apr 29;42(17):1968-71. doi: 10.1002/anie.200219978. Angew Chem Int Ed Engl. 2003. PMID: 12730984 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

214 results

Search Page

Filters